In adult T-cell leukemia/lymphoma (ATLL), ETS1 is highly expressed in patients of North American descent and promotes tumor growth by regulating CCR4, making it a potential therapeutic target (180, 181). This evidence concerns the gene ETS1 and adult T-cell leukemia/lymphoma.